| |
| |
|
| Insider
Information: |
Ueno Ryuji |
| Relationship: |
10% Owner |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sucampo Pharmaceuticals, Inc. |
SCMP |
10% Owner |
2015-03-31 |
0 |
2018-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-07-08 |
4 |
AS |
$6.48 |
$182,450 |
I/I |
(28,162) |
25,103,412 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-07-09 |
4 |
AS |
$6.49 |
$66,810 |
I/I |
(10,300) |
25,093,112 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-07-22 |
4 |
AS |
$6.57 |
$35,873 |
I/I |
(5,462) |
25,087,650 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-07-23 |
4 |
AS |
$6.60 |
$81,158 |
I/I |
(12,300) |
25,075,350 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-07-24 |
4 |
AS |
$6.46 |
$133,805 |
I/I |
(20,700) |
25,054,650 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-08-05 |
4 |
AS |
$6.20 |
$88,991 |
I/I |
(14,362) |
25,040,288 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-08-06 |
4 |
AS |
$6.21 |
$149,671 |
I/I |
(24,100) |
25,016,188 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-08-19 |
4 |
AS |
$6.04 |
$232,257 |
I/I |
(38,462) |
24,977,726 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-09-03 |
4 |
AS |
$5.59 |
$214,887 |
I/I |
(38,462) |
24,939,264 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-09-16 |
4 |
AS |
$5.64 |
$82,700 |
I/I |
(14,662) |
24,924,602 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-09-17 |
4 |
AS |
$5.73 |
$72,207 |
I/I |
(12,600) |
24,912,002 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-09-18 |
4 |
AS |
$5.69 |
$63,754 |
I/I |
(11,200) |
24,900,802 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-10-16 |
4 |
AS |
$6.35 |
$2,287,116 |
I/I |
(360,000) |
24,540,802 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2013-11-25 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,000,000 |
23,540,802 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2014-01-17 |
4 |
AS |
$10.36 |
$3,728,412 |
I/I |
(360,000) |
24,180,802 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific OfficerO |
• • • |
2007-08-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,872,252 |
|
- |
|
91 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
